Treatment challenges associated with bone echinococcosis.

Steinmetz, Sylvain; Racloz, Guillaume; Stern, Richard; Dominguez, Dennis; Al-Mayahi, Mohamed; Schibler, Manuel; Lew, Daniel; Hoffmeyer, Pierre; Uçkay, Ilker

Steinmetz, Sylvain; Racloz, Guillaume; Stern, Richard; Dominguez, Dennis; Al-Mayahi, Mohamed; Schibler, Manuel; Lew, Daniel; Hoffmeyer, Pierre; Uçkay, Ilker.

Affiliation

Steinmetz S; Orthopaedic Surgery Service, Geneva University Hospitals and Faculty of Medicine, University of Geneva, Geneva, Switzerland.

J Antimicrob Chemother ; 69(3): 821-6, 2014 Mar.

Article in En | MEDLINE | ID: mdl-24222611

Subject(s)

Bone Diseases/drug therapy; Bone Diseases/epidemiology; Echinococcosis/drug therapy; Echinococcosis/epidemiology; Echinococcus granulosus/isolation & purification; Albendazole/therapeutic use; Animals; Anthelmintics/therapeutic use; Bone Diseases/parasitology; Bone Diseases/surgery; Debridement; Echinococcosis/parasitology; Echinococcosis/surgery; Humans; Mebendazole/therapeutic use; Recurrence; Time Factors; Treatment Outcome

Key words

benzimidazoles; epidemiology; orthopaedic surgery; recurrence

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Bone Diseases / Echinococcus granulosus / Echinococcosis Type of study: Prognostic_studies / Risk_factors_studies Limits: Animals / Humans Language: En Journal: J Antimicrob Chemother Year: 2014 Type: Article Affiliation country: Switzerland

Fulltext

XML

PubMed Links

Search on Google